BACKGROUND: GLP-1 receptor agonists (GLP-1RAs) are effective for treating type 2 diabetes mellitus (T2DM) and promoting weight loss, but not all patients respond similarly. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.